Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →

Shortage Avoided

MYLAN-SUMATRIPTAN

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MYLAN-SUMATRIPTAN in Canada?

A shortage of MYLAN-SUMATRIPTAN 50MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 22, 2026), but it has not started yet.

Why is MYLAN-SUMATRIPTAN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MYLAN-SUMATRIPTAN be available again?

The manufacturer's estimated resolution date is February 9, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusShortage Avoided
Same-ingredient products on fileNone found
Affected strength50MG
Last updated2020-12-22

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02268914

Strength

50MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

SUMATRIPTAN

Tier

Unrated

Last Updated

2020-12-22

Reason for Shortage

Shortage of an inactive ingredient or component.

Past Reports for This Drug

MYLAN-SUMATRIPTAN has 2 shortage/discontinuation reports on file — this is one of them.